Canonical Hh pathway regulates osteogenic differentiation of human cervical PLL cells by BMP signalling pathway, implying that antagonising the Hh pathway or GLI1 could be a promising therapeutic approach for OPLL in the future. The gene discussed is GLI1; the disease is ossification of the posterior longitudinal ligament of the spine.